Medical Devices Company Investment Opportunity in New Delhi, India
Company developing protective solutions for pollution using patented nanofiber technology in a US $56B market.
This transaction has concluded.
Premium Plan
| Established | 5-10 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 40 thousand |
| Run Rate Sales | USD 175 thousand |
| EBITDA Margin | 10 % |
| Industries | Medical Devices |
| Locations | New Delhi |
| Local Time | 11:15 AM Asia / Kolkata |
| Listed By | Advisor / Business Broker |
| Status | Active |
Partial Stake Sale
USD
610 thousand
for
19.0%
stake
(Native Currency: INR 58,500,000)
Reason: For further growth and expansion. The valuation is based on the US $56B market size along with its r...
View More
Includes physical assets worth
USD
44 thousand
Documents
Pitch Deck
(7.3 MB)
Advertisement
(109.1 KB)
Team
(100.3 KB)
Promotional Material
(8.2 KB)
Logo
(4.4 KB)
ROC-Verification.pdf
(302.3 KB)
Business Overview
Key highlights:
- Innovation: The company has launched the world’s first smoking cessation filter, to reduce nicotine intake.
- Market: Operating in a US $56B market with INR ₹15 lakhs MRR and a 40% repeat order rate.
- Financials: Gross margins are projected to improve from 48% in last year to 70% by next year.
- Awards: Received the Startup National Award from the President of India.
- R&D Support: Backed by IIT Delhi with 4 granted IPs and INR 1.8 crore in government R&D grants.
- Global expansion: Exporting to the US, Spain, Iran, and Vietnam with ongoing partnerships.
- High growth is attributed to an increase in demand for the product due to being featured on a very popular TV show.
- Innovation: The company has launched the world’s first smoking cessation filter, to reduce nicotine intake.
- Market: Operating in a US $56B market with INR ₹15 lakhs MRR and a 40% repeat order rate.
- Financials: Gross margins are projected to improve from 48% in last year to 70% by next year.
- Awards: Received the Startup National Award from the President of India.
- R&D Support: Backed by IIT Delhi with 4 granted IPs and INR 1.8 crore in government R&D grants.
- Global expansion: Exporting to the US, Spain, Iran, and Vietnam with ongoing partnerships.
- High growth is attributed to an increase in demand for the product due to being featured on a very popular TV show.
Products & Services Overview
Company aiming to help reduce pollution caused by smoking. It developed protective solutions for polluted air using its patented nanofiber technology. The company has also been credited with launching the world’s first smoking cessation filter, to reduce nicotine intake.
Assets Overview
Tangible assets include:- Machinery.
- Furniture.
Facilities Overview
Operations are currently run from an incubation center at a popular college.
Capitalization Overview
There are four directors who hold 100% of the firm and there are no loans at the moment.
Recent Activity
-
Director, Mumbai, Financial Consultant connected with the Business
-
Sales Associate, Makati City, Financial Consultant connected with the Business
Tags:
Medical Equipment Company Investment Opportunity in New Delhi, India
·Medical Devices Company Investment Opportunity in New Delhi, India
·Invest in Medical Equipment Company in New Delhi, India
·Invest in Medical Devices Company in New Delhi, India
·Medical Equipment Company Investment Opportunity
·Medical Devices Company Investment Opportunity
·Investment Opportunity in New Delhi, India
·Invest in Medical Equipment Company
·Invest in Medical Devices Company
·Invest in New Delhi, India
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
